Warberg Asset Management LLC raised its position in Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Free Report) by 47.1% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,781 shares of the company’s stock after purchasing an additional 12,741 shares during the quarter. Warberg Asset Management LLC’s holdings in Bellevue Life Sciences Acquisition were worth $429,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of BLAC. Berkley W R Corp purchased a new position in Bellevue Life Sciences Acquisition in the first quarter valued at approximately $3,440,000. Mizuho Securities USA LLC purchased a new position in shares of Bellevue Life Sciences Acquisition in the 4th quarter valued at $1,388,000. K2 Principal Fund L.P. purchased a new position in shares of Bellevue Life Sciences Acquisition in the 1st quarter valued at $358,000. Cowen AND Company LLC acquired a new position in shares of Bellevue Life Sciences Acquisition during the 4th quarter valued at $165,000. Finally, Condor Capital Management purchased a new stake in Bellevue Life Sciences Acquisition during the 4th quarter worth $121,000. Hedge funds and other institutional investors own 55.30% of the company’s stock.
Bellevue Life Sciences Acquisition Stock Performance
Shares of NASDAQ BLAC opened at $10.91 on Friday. The stock has a fifty day moving average price of $10.84 and a 200 day moving average price of $10.76. Bellevue Life Sciences Acquisition Corp. has a 12-month low of $10.38 and a 12-month high of $11.60.
Bellevue Life Sciences Acquisition Profile
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington.
Featured Articles
- Five stocks we like better than Bellevue Life Sciences Acquisition
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Want to see what other hedge funds are holding BLAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Free Report).
Receive News & Ratings for Bellevue Life Sciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
